Dual secured nano-melittin for the safe and effective eradication of cancer cells.
Ontology highlight
ABSTRACT: The clinical application of natural and synthetic amphipathic peptides (e.g., melittin) for cancer therapy is hindered by their notorious side effect, lysing red blood cells. To safely deliver a therapeutic peptide to the tumor tissue and kill cancer cells, we developed an environment-sensitive peptide delivery system, dual secured nano-sting (DSNS), through the combination of a zwitterionic glycol chitosan and disulfide bonds. Melittin loaded DSNS could kill almost 100% of MCF-7, HCT-116, SKOV-3, and NCI/ADR-RES (multidrug resistant) cancer cells at the concentration of 5 μM, while not showing any hemolytic effect.
SUBMITTER: Bei C
PROVIDER: S-EPMC4342614 | biostudies-literature | 2015 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA